3IP
GILD icon

3Chopt Investment Partners’s Gilead Sciences GILD Stock Holding History

3Chopt Investment Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.85M Sell
22,571
-584
-3% -$76.9K 0.54% 41
2026
Q1 		$3.23M Sell
23,155
-417
-2% -$58.4K 0.74% 29
2025
Q4 		$2.89M Sell
23,572
-64
-0.3% -$7.78K 0.65% 35
2025
Q3 		$2.62M Buy
23,636
+1,474
+7% +$168K 0.6% 41
2025
Q2 		$2.46M Buy
22,162
+3,318
+18% +$353K 0.59% 45
2025
Q1 		$2.11M Buy
+18,844
New +$1.94M 0.55% 48

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

3Chopt Investment Partners's GILD Position: Q2 2026 in Review

3Chopt Investment Partners reduced its Gilead Sciences (GILD) stake by 2.5% in Q2 2026, selling an estimated $76.9K and leaving 22,571 shares worth $2.85M. The position accounts for 0.54% of the portfolio, ranked #41.

3Chopt Investment Partners first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.23M in Q1 2026. 1,376 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • 3Chopt Investment Partners held 22,571 shares of Gilead Sciences worth $2.85M as of Q2 2026.
  • 3Chopt Investment Partners sold 584 Gilead Sciences shares in Q2 2026, an estimated $76.9K.
  • Gilead Sciences made up 0.54% of 3Chopt Investment Partners's portfolio in Q2 2026, its #41 holding.
  • 3Chopt Investment Partners first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • 3Chopt Investment Partners's Gilead Sciences position peaked at $3.23M in Q1 2026.
  • 1,376 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on 3Chopt Investment Partners's 13F filing for Q2 2026, filed 29 Jul 2026.